123 related articles for article (PubMed ID: 29907585)
1. Antibiotics Protect against Liver Tumors in Mice.
Cancer Discov; 2018 Aug; 8(8):905-906. PubMed ID: 29907585
[TBL] [Abstract][Full Text] [Related]
2. Bile Acids, the Microbiome, Immunity, and Liver Tumors.
Schramm C
N Engl J Med; 2018 Aug; 379(9):888-890. PubMed ID: 30157405
[No Abstract] [Full Text] [Related]
3. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.
Ma C; Han M; Heinrich B; Fu Q; Zhang Q; Sandhu M; Agdashian D; Terabe M; Berzofsky JA; Fako V; Ritz T; Longerich T; Theriot CM; McCulloch JA; Roy S; Yuan W; Thovarai V; Sen SK; Ruchirawat M; Korangy F; Wang XW; Trinchieri G; Greten TF
Science; 2018 May; 360(6391):. PubMed ID: 29798856
[TBL] [Abstract][Full Text] [Related]
4. Commentary: Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.
Jia B
Front Immunol; 2019; 10():282. PubMed ID: 30842777
[No Abstract] [Full Text] [Related]
5. Gut microbiota as gatekeeper of anti-tumour responses in the liver.
Adolph TE; Tilg H
Nat Rev Gastroenterol Hepatol; 2018 Oct; 15(10):584-586. PubMed ID: 30013103
[No Abstract] [Full Text] [Related]
6. Gut microbiota bile acid metabolism controls cancer immunosurveillance.
Dart A
Nat Rev Microbiol; 2018 Aug; 16(8):453. PubMed ID: 29946123
[No Abstract] [Full Text] [Related]
7. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
[TBL] [Abstract][Full Text] [Related]
8. Promotion and induction of liver cancer by gut microbiome-mediated modulation of bile acids.
Jia B; Jeon CO
PLoS Pathog; 2019 Sep; 15(9):e1007954. PubMed ID: 31487329
[No Abstract] [Full Text] [Related]
9. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
Cho MS; Kim SY; Suk KT; Kim BY
J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility.
Ge X; Ding C; Zhao W; Xu L; Tian H; Gong J; Zhu M; Li J; Li N
J Transl Med; 2017 Jan; 15(1):13. PubMed ID: 28086815
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism.
Just S; Mondot S; Ecker J; Wegner K; Rath E; Gau L; Streidl T; Hery-Arnaud G; Schmidt S; Lesker TR; Bieth V; Dunkel A; Strowig T; Hofmann T; Haller D; Liebisch G; Gérard P; Rohn S; Lepage P; Clavel T
Microbiome; 2018 Aug; 6(1):134. PubMed ID: 30071904
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
[TBL] [Abstract][Full Text] [Related]
13. Role of Gut Microbiota in Liver Disease.
Brenner DA; Paik YH; Schnabl B
J Clin Gastroenterol; 2015; 49 Suppl 1(0 1):S25-7. PubMed ID: 26447960
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
Sethi V; Kurtom S; Tarique M; Lavania S; Malchiodi Z; Hellmund L; Zhang L; Sharma U; Giri B; Garg B; Ferrantella A; Vickers SM; Banerjee S; Dawra R; Roy S; Ramakrishnan S; Saluja A; Dudeja V
Gastroenterology; 2018 Jul; 155(1):33-37.e6. PubMed ID: 29630898
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Bäckhed F; Marschall HU
Dig Dis; 2017; 35(3):246-250. PubMed ID: 28249261
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
[TBL] [Abstract][Full Text] [Related]
17. Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics.
Behr C; Sperber S; Jiang X; Strauss V; Kamp H; Walk T; Herold M; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2018 Sep; 355():198-210. PubMed ID: 30008377
[TBL] [Abstract][Full Text] [Related]
18. Consequences of bile salt biotransformations by intestinal bacteria.
Ridlon JM; Harris SC; Bhowmik S; Kang DJ; Hylemon PB
Gut Microbes; 2016; 7(1):22-39. PubMed ID: 26939849
[TBL] [Abstract][Full Text] [Related]
19. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
[TBL] [Abstract][Full Text] [Related]
20. In vitro probiotic characteristics of Lactobacillus plantarum ZDY 2013 and its modulatory effect on gut microbiota of mice.
Huang R; Tao X; Wan C; Li S; Xu H; Xu F; Shah NP; Wei H
J Dairy Sci; 2015 Sep; 98(9):5850-61. PubMed ID: 26142853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
